Home/Pipeline/Casdatifan

Casdatifan

Late-line Kidney Cancer

Phase 3Active - Global study enrolling

Key Facts

Indication
Late-line Kidney Cancer
Phase
Phase 3
Status
Active - Global study enrolling
Company

About Arcus Biosciences

Arcus Biosciences is a Hayward, California-based oncology company pioneering the development of combination cancer therapies. Founded in 2015 by industry veterans Terry Rosen and Juan Jaen, the company has built an integrated platform from discovery through commercialization, advancing molecules from IND to Phase 1 in as little as 18 months. With a focus on well-understood biological pathways, Arcus aims to accelerate the delivery of new treatment options through strategic partnerships with the cancer community and a pipeline featuring both oncology and inflammation programs.

View full company profile

About Arcus Biosciences

Arcus Biosciences is a Hayward, California-based oncology company pioneering the development of combination cancer therapies. Founded in 2015 by industry veterans Terry Rosen and Juan Jaen, the company has built an integrated platform from discovery through commercialization, advancing molecules from IND to Phase 1 in as little as 18 months. With a focus on well-understood biological pathways, Arcus aims to accelerate the delivery of new treatment options through strategic partnerships with the cancer community and a pipeline featuring both oncology and inflammation programs.

View full company profile

Therapeutic Areas